Due to health issues, this site is no longer maintained and will be shut down shortly. |
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota. This security was issued by PetVivo Holdings Inc, whose common stock symbol is PETV.
$0.48 0.00 (0.00%)
As of 03/24/2023 00:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.